Exclusive

Publication

Byline

NHAI Tightens AI-Machine Construction Norms

Mumbai, Sept. 2 -- New Delhi: The National Highways Authority of India (NHAI) has significantly tightened its framework for Automated and Intelligent Machine-Aided Construction (AI-MC), introducing pr... Read More


Nairobi's expansion is swallowing up rural land: new book reveals the impacts on families

India, Sept. 2 -- Nairobi's transformation into a "world-class city" is both anticipated and celebrated in Kenya's media. A new book, Peasants to Paupers: Land, Class and Kinship in Central Kenya, exa... Read More


Power Investments to Drive 100-200 bps Revenue Growth for Large EPC Firms

Mumbai, Sept. 2 -- Rising power sector investments, steady public infrastructure spending, and expanding overseas contracts will drive EPC revenue growth this fiscal. Large, diversified engineering, ... Read More


Thailand LAB INTERNATIONAL 2026 Opens in Bangkok, Putting Asia's Lab and Life Sciences Innovation in Focus

Singapore, Sept. 2 -- Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), bringing together the laboratory, biotechnology, chemicals and lif... Read More


Most Assets Die on Fit, Not on Data

Singapore, Sept. 2 -- "Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens earlier in the process than founders imagine, and for rea... Read More


Bridges Are Not Symmetrical: Reading the Asia Bio Cross-Border Keynote

Singapore, Sept. 2 -- Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a structure with one engineered end and one improvised end, and S... Read More


Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30

Singapore, Sept. 2 -- Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investigational once-daily oral small molecule GLP-1 receptor agon... Read More


Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis

Singapore, Sept. 2 -- Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran for transthyretin amyloidosis. From 1 September 2026, vut... Read More


Singapore expands subsidised access to Roche's Columvi for relapsed or refractory DLBCL

Singapore, Sept. 2 -- Singapore is expanding subsidised access to Roche's Columvi, or glofitamab, for eligible patients with relapsed or refractory diffuse large B-cell lymphoma. From 1 September 202... Read More


4 big games are joining Xbox Game Pass in September 2026

India, Sept. 1 -- September may have fewer Xbox Game Pass additions than August, but the lineup has more than enough weight to keep subscribers busy. Microsoft is adding 4 games during the month, incl... Read More